Condensed Consolidated Statements of Cash Flows (USD $)	9 Months Ended
	Sep. 30, 2013	Sep. 30, 2012
Cash Flows From Operating Activities
Net loss from continuing operations	$ (3,282,266)	$ (419,027)
Adjustments to reconcile net loss to net cash and cash equivalents used in operating activities:
Stock-based compensation	2,951	0
Depreciation and amortization	672,828	425,238
Non-cash interest relating to convertible debt and loan cost amortization	217,290	1,027,713
Non-cash compensation relating to business combination	4,418,524	0
Changes in operating assets and liabilities, net of those acquired in business combination:
Accounts receivable	(4,082,695)	(518,429)
Inventories	525	(387,172)
Prepaid expenses	(188,143)	83,031
Accounts payable	93,280	87,897
Accrued expenses, returned goods reserve and deferred revenue	(382,858)	188,271
Net Cash and Cash Equivalents (Used in)/Provided by Continuing Operations	(2,530,564)	487,522
Net Cash Used in Discontinued Operation	(88,816)	(65,917)
Net Cash and Cash Equivalents (Used in)/Provided by Operating Activities	(2,619,380)	421,605
Cash Flows From Investing Activities
Cash acquired in business combination	18,197,442	0
Acquisition of property and equipment, net of disposals	(161,415)	(76,888)
Net Cash and Cash Equivalents Provided by/(Used in) Investing Activities	18,036,027	(76,888)
Cash Flows From Financing Activities
(Repayments)/borrowings under line of credit, net	(4,065,307)	364,362
Payment of debt issuance costs	0	(260,748)
Treasury stock purchases	(432,562)	0
Net Cash and Cash Equivalents Used in Continuing Operations	(4,497,869)	103,614
Net Cash Used in Discontinued Operation	0	(300,000)
Net Cash and Cash Equivalents Used in Financing Activities	(4,497,869)	(196,386)
Change in Cash and Cash Equivalents	10,918,778	148,331
Cash and cash equivalents, beginning of period	11,028	0
Cash and cash equivalents, end of period	10,929,806	148,331
Supplemental disclosure for cash flow information:
Cash paid for interest	249,612	211,424
Supplemental non-cash investing and financing activities:
Issuance of common stock in business combination	40,033,695	0
Cancellation of Series D, Series C, Series B, Series A, and common stock	57,296,106	0
Acquired intangibles	10,900,000	0
Acquired goodwill	1,838,309	0
Acquired restricted cash	2,260,100	0
Other acquired tangible assets	79,261	0
Assumed liabilities	3,479,979	0
Preferred stock dividends	4,974,199	4,326,622
Issuance of common and preferred stock upon cashless warrant exercise	0	4,984
Issuance of preferred stock upon convertible debt conversion	$ 0	$ 17,609,646